Literature DB >> 6732348

Myasthenia gravis with thymoma: analysis of and postoperative prognosis for 65 patients with thymomatous myasthenia gravis.

Y Monden, K Nakahara, K Kagotani, Y Fujii, A Masaoka, Y Kawashima.   

Abstract

Sixty-five patients with thymomatous myasthenia gravis were investigated. Thymomas were present in 44% of the male patients and 19% of the female patients with myasthenia gravis. The incidence of thymomatous disease in male patients was higher than in female patients in all age groups. Eighty percent of men more than 50 years old and women more than 60 years old had myasthenia gravis with thymoma. Germinal center formation in the thymus of patients with thymomatous myasthenia gravis was positive in 91% and was high grade. The prognosis for patients undergoing extended thymectomy of thymomatous myasthenia gravis was significantly better than in those having transsternal simple thymectomy, but it was worse than the prognosis for patients with nonthymomatous myasthenia gravis. No increase in the rate of remission or palliation was seen one year after thymectomy. It is concluded that early thymectomy is effective in control of myasthenia gravis in thymomatous myasthenia gravis.

Entities:  

Mesh:

Year:  1984        PMID: 6732348     DOI: 10.1016/s0003-4975(10)62185-6

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  13 in total

1.  Thymus cells in myasthenia gravis: a two-colour flow cytometric analysis of lymphocytes in the thymus and thymoma.

Authors:  Y Fujii; M Hayakawa; K Nakahara
Journal:  J Neurol       Date:  1992-02       Impact factor: 4.849

2.  Circulating CD4+CD8+ cells in myasthenia gravis: supplementary immunological parameter for long-term prognosis.

Authors:  M Matsui; H Fukuyama; I Akiguchi; M Kameyama
Journal:  J Neurol       Date:  1989-09       Impact factor: 4.849

3.  Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients.

Authors:  A Melms; B C Schalke; T Kirchner; H K Müller-Hermelink; E Albert; H Wekerle
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

4.  Oncological significance of WHO histological thymoma classification. A clinical study based on 286 patients.

Authors:  Meinoshin Okumura; Mitsunori Ohta; Shinichiro Miyoshi; Takashi Mori; Tsutomu Yasumitsu; Kazuya Nakahara; Keiji Iuchi; Hiroto Tada; Hajime Maeda; Hikaru Matsuda
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-05

5.  Myasthenia gravis induces the activation and maturation of lymphocytes in thymoma.

Authors:  K Takahashi; Y Monden; S Saito; Y Kamamura; T Uyama
Journal:  J Clin Immunol       Date:  1996-07       Impact factor: 8.317

Review 6.  Clinical and pathological aspects of thymic epithelial tumors.

Authors:  Meinoshin Okumura; Hiroyuki Shiono; Masato Minami; Masayoshi Inoue; Tomoki Utsumi; Yoshihisa Kadota; Yoshiki Sawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-01-22

7.  Thymectomy for myasthenia gravis: 14-year experience.

Authors:  J R Hankins; R F Mayer; J R Satterfield; S Z Turney; S Attar; A J Sequeira; B W Thompson; J S McLaughlin
Journal:  Ann Surg       Date:  1985-05       Impact factor: 12.969

Review 8.  Myasthenia gravis and thymic neoplasms: A brief review.

Authors:  Ritesh Kumar
Journal:  World J Clin Cases       Date:  2015-12-16       Impact factor: 1.337

9.  Thymectomy in the treatment of myasthenia gravis: report of 247 patients.

Authors:  A Evoli; A P Batocchi; C Provenzano; E Ricci; P Tonali
Journal:  J Neurol       Date:  1988-05       Impact factor: 4.849

10.  Superior vena caval syndrome and ipsilateral pleural effusion: A rare presentation of anterior mediastinal thymoma.

Authors:  Anirban Das; Sudipta Pandit; Sabyasachi Choudhury; Sibes K Das; Sumitra Basuthakur
Journal:  Lung India       Date:  2014-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.